This judgement is one of many issued in the worldwide litigation pending between Novartis and Johnson & Johnson concerning Novartis' patent for ophthalmically compatible extended wear contact…
In a recent post of mine I have reported that by decision of 29 July 2010, the Italian Supreme Administrative Court (Consiglio di Stato) had tackled the issue of whether the Italian drugs regulatory…
Once again, the German Federal Supreme Court has underlined the primacy of the patent claim over the patent's description. The technical problem to be solved by the invention is to be established by…
The UK has long been considered a favourable jurisdiction for pharmaceutical patent holders to seek an interim or preliminary injunction. In particular, from 2001 the English Courts have imposed an…
The Court of Appeal allowed Grimme's appeal, holding that Grimme's patent for an agricultural machine for harvesting and separating potatoes (from other materials such as earth, clods, stones, weeds…
Vitreo's patent application for 'means for application of a vitreous body for the purposes of prevention and medical treatment of ophthalmic disorders' was denied by the patent office, because the…
In Italy, patent cases are heard by judges of the IP Chambers of 12 district courts distributed in the Italian territory. Italian judges are therefore IP specialists, but they have a merely legal,…
Patent protection for technical products expires after 20 years. However, there is no rule without exception. In its recent decision "Femur-Teil"(judgement of 15 April 2010, I ZR 145/08), the German…
Under Spanish law, when the first generic version of a medicament of reference (i.e. original medicament) is authorized, the setting of the price of the generic triggers the inclusion of the…
Denmark, as one of only a very few countries in the Western world, has no specialty patents court(s) for first instance PI proceedings.
Instead, an application for a PI is heard by the bailiff's…
